【AEA 2018 Alumni】
The Brain Beat Glucometer (BBG) is the blood glucose non-invasive self-monitoring device for Diabetes Mellitus sufferers. Unlike the traditional methods of monitoring blood glucose, BBG causes absolutely no pain or discomfort to the user and will immeasurably improve the quality of life of diabetic patients. It also offers significant cost savings by eliminating the need for expensive consumables, which cost the average diabetic approximately €3,118 per annum.
Brain Beat team has over 50 years cumulated research experience in the fields of biophysics, high performance computing and medicine, and over 32 years experience creating, growing and managing successful start-ups and companies in biotech industry. The company has developed a pre-production prototype and holds negotiations with large medical device manufacturers on licensing the technology to them for manufacturing and distribution of the device through their own established networks. Discussions are underway with potential key stakeholders such as LifeScan, Abbott and LG.